Effect of royal jelly on experimental colitis Induced by acetic acid and alteration of mast cell distribution in the colon of rats.
This study investigated the effects of royal jelly (RJ) on acetic acid-induced colitis in rats. Twenty adult female Wistar albino rats were divided into four treatment groups of 5 animals each, including a control group (Group I); Group II was treated orally with RJ (150 mg kg(-1) body weight); Group III had acetic acid-induced colitis; and Group IV had acetic acid-induced colitis treated orally with RJ (150 mg kg(-1) body weight) for 4 weeks. Colitis was induced by intracolonic instillation of 4% acetic acid; the control group received physiological saline (10 mL kg(-1)). Colon samples were obtained under deep anaesthesia from animals in all groups. Tissues were fixed in 10% formalin neutral buffer solution for 24 h and embedded in paraffin. Six-micrometre-thick sections were stained with Mallory’s triple stain and toluidine blue in 1% aqueous solution at pH 1.0 for 5 min (for Mast Cells). RJ was shown to protect the colonic mucosa against the injurious effect of acetic acid. Colitis (colonic damage) was confirmed histomorphometrically as significant increases in the number of mast cells (MC) and colonic erosions in rats with acetic acid-induced colitis. The RJ treatment significantly decreased the number of MC and reduced the area of colonic erosion in the colon of RJ-treated rats compared with rats with untreated colitis. The results suggest that oral treatment with RJ could be used to treat colitis.
Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Yuzuncu Yil, Van, Turkey. turankaraca@yyu.edu.tr
T
T
Karaca
F
F
Bayiroglu
M
M
Yoruk
M S
MS
Kaya
S
S
Uslu
B
B
Comba
L
L
Mis
D019342:Acetic Acid / Q000633:toxicity; D000818:Animals; D002478:Cells, Cultured; D003092:Colitis / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D005227:Fatty Acids / Q000627:therapeutic use*; D005260:Female; D007202:Indicators and Reagents / Q000633:toxicity; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D008407:Mast Cells / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D000099219:Royal Jelly
D019342:Acetic Acid; D005227:Fatty Acids; D007202:Indicators and Reagents; D000099219:Royal Jelly
Gut. 1987 May;28(5):588-93
3596340
J Cell Biochem Suppl. 1997;27:59-67
9591194
Allergol Immunopathol (Madr). 2006 Sep-Oct;34(5):228-30
17064653
J AOAC Int. 1995 Jul-Aug;78(4):1019-23
7580313
Phytother Res. 2006 Jul;20(7):585-90
16673449
Methods Mol Biol. 2006;315:123-38
16110154
Exp Dermatol. 1999 Jun;8(3):167-76
10389633
Histopathology. 1996 Jan;28(1):1-13
8838115
Int Immunopharmacol. 2003 Sep;3(9):1313-24
12890429
J Nutr Sci Vitaminol (Tokyo). 2005 Jun;51(3):148-55
16161764
Toxicon. 2007 Aug;50(2):256-69
17490698
Allergol Immunopathol (Madr). 2008 Sep-Oct;36(5):271-6
19080799
Gastroenterology. 1989 Mar;96(3):795-803
2914642
J Agric Food Chem. 2006 Dec 27;54(26):10288-93
17177572
Gut. 1999 Aug;45(2):210-7
10403732
Gut. 1999 May;44(5):643-52
10205200
Scand J Gastroenterol. 2002 May;37(5):555-60
12059057
J Agric Food Chem. 2006 Oct 18;54(21):8328-34
17032047
Gut. 1996 Jan;38(1):104-14
8566835
Carcinogenesis. 2003 Aug;24(8):1369-78
12819184
J Pharmacol Exp Ther. 2005 Dec;315(3):1172-80
16123309
Toxicology. 2003 Feb 1;183(1-3):133-42
12504347
J Vet Sci. 2004 Sep;5(3):189-95
15365232
Biosci Biotechnol Biochem. 2004 Jan;68(1):138-45
14745176
Int Immunopharmacol. 2001 Mar;1(3):521-32
11367535
Life Sci. 2003 Sep 5;73(16):2029-45
12899927
J Nutr. 2002 Jan;132(1):11-9
11773501
Arch Toxicol. 2006 Apr;80(4):217-24
16240107
Exp Toxicol Pathol. 2009 Mar;61(2):123-32
18693095
Biosci Biotechnol Biochem. 2007 Jan;71(1):253-5
17213647
Scand J Gastroenterol. 2002 Mar;37(3):330-7
11916196
Eur J Immunol. 1999 May;29(5):1496-503
10359103
Hum Exp Toxicol. 2010 Apr;29(4):321-8
20154102
J Ethnopharmacol. 2000 Sep;72(1-2):299-304
10967486